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ABSTRACT 
A number of chemicals, mostly adenosine analogues, cause the nucleolus of the 
chick embryo fibroblast to lose material and unravel over a period of several hours 
into beaded strands termed nucleolar necklaces (NN). The results of analyses of 
the fibroblasts, treated with the NN-forming chemical dichlororibobenzimidazole 
(DRB),  suggest  that  the  following biochemical alterations occur:  DRB  almost 
completely prevents the increase in both messenger RNA (mRNA) and heteroge- 
neous nuclear RNA. It interferes with ribosome synthesis by decreasing the rate of 
45S ribosomal RNA (rRNA) accumulation by 50% slowing the rate of 18S rRNA 
appearance by 50%, and causing an extensive degradation (80%) of the 32S and 28S 
rRNA-containing preribosomes. Most of this preribosome degradation probably 
occurs at or before the 32S  rRNA preribosome stage. The degradation of these 
preribosomes  appears  to  be  due  to  the  formation  of  defective  45S  rRNA 
preribosomes rather than to a direct DRB interference with preribosome process- 
ing enzyme action. DRB inhibits total cellular RNA synthesis in less than 15 min, 
suggesting a direct interference with RNA synthesis. DRB also inhibits the uptake 
of nucleosides into the cell.  DRB in the concentrations used does not appear to 
directly interfere with the translation of mRNA  (i.e.,  protein  synthesis).  Other 
NN-forming adenosine analogues and high concentrations of adenosine (2 raM) 
cause biochemical alterations similar to those produced by DRB. To explain the 
preribosome  degradation,  we  propose  the  hypothesis  that  DRB  inhibits  the 
synthesis of mRNA; as a  consequence, some of the preribosomal proteins that 
normally coat the 32S rRNA portion of the 45S precursor RNA become limiting, 
and this defective portion is then subject  to degradation by nucleases. 
A number of adenosine analogues, and even aden- 
osine itself in high concentrations (2 mM), inter- 
fere with ribosome synthesis  and cause fragmenta- 
tion of the nucleolus which is the ribosome syn- 
thetic center of the cell. Toyocamycin in  HeLa 
cells (29) and 5-bromotubercidin in chick embryo 
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decrease the rate of 45S ribosomal RNA (rRNA) 
accumulation and almost completely halt its subse- 
quent "processing" or conversion to 32S, 28S, and 
18S  rRNAs. ~ Tavitian  et  al.  (29)  suggested  that 
toyocamycin caused  these biochemical alterations 
by  being  inserted  into the growing rRNA chains. 
The effects of these chemicals vary somewhat with 
cell type. 
In CEF cells we have found that the alterations 
in  the  nucleolar  morphology  caused  by  these 
adenosine  analogues  are particularly  striking:  the 
round  CEF  cell  nucleoli  lose  material  and  the 
remaining  fragments  unravel  into  long  (20  um) 
beaded  strands  termed  nucleolar  necklaces  (NN) 
(9).  NN  formation  in  CEF  cells  was  initially 
observed  after the addition of high concentrations 
(2  mM)  of adenosine  (16,  17).  These  chemically 
produced  NN  are  similar  in  appearance  to  those 
formed  when  CEF  cells  are  grown  in  a  medium 
deficient in the amino acid arginine (11). 
In this paper we report biochemical studies on a 
number of the NN-forming chemicals in CEF cell 
cultures.  The  chemicals  investigated  were:  toyo- 
camycin,  5-bromotubercidin,  5,6-dichloro-l-(B-D- 
ribofuranosyl)benzimidazole  (DRB),  2-mercapto- 
l-(2-[4-pyridyl]ethyl)benzimidazole (MPB), 2 mM 
adenosine,  and  a-amanitin.  Although  the  bio- 
chemical actions  of some of these chemicals such 
as  toyocamycin  and  bromotubercidin  have  been 
well  characterized  (29,  2),  less  is  known  about 
the  action  of the others.  Our  investigations place 
special emphasis on reactions which are directly or 
~Abbreviations  used  in  this  paper.  AIA,  allyliso- 
propylacetamide;  ALA,  A-aminolevulinic  acid;  CEF, 
chick  embryo  fibroblast;  DRB,  5,6-dichloro-l-(B-D- 
ribofuranosyl)benzimidazole;  HnRNA,  heterogeneous 
nuclear RNA; MPB, 2-mercapto-l-(2-[4-pyridyl]ethyl)- 
benzimidazole; mRNA, messenger RNA; NN,  nucleo- 
lar necklaces; rRNA, ribosomal RNA; tRNA, transfer 
RNA; 45S rRNA preribosome, preribosome containing 
45S rRNA. 
~The  HeLa  cell  nucleolus  synthesizes  a  "preribo- 
some" consisting of a 45S rRNA strand which is coated 
with  ribosomal proteins (1).  The processing of the 45S 
rRNA, according to Wellaur and  Dawid (36),  proceeds 
as follows: first, a piece of rRNA is cleaved off at the 3' 
end  and  discarded,  leaving a  41S  RNA.  The  latter  is 
then cleaved into two preribosomes, one containing 32S 
RNA and the other containing 20S RNA. The 20S RNA 
in the preribosome is trimmed to become the cytoplasmic 
ribosome containing 18S RNA, and the 32S RNA in its 
preribosome is trimmed to become the cytoplasmic ribo- 
some containing 28S RNA. 
indirectly  related  to  the  synthesis  of  ribosomes 
such  as:  the  synthesis  of  messenger  RNA 
(mRNA), heterogeneous nuclear RNA (HnRNA), 
transfer  RNA (tRNA), protein  synthesis,  and the 
synthesis of the 45S ribosomal precursor RNA and 
its  subsequent  processing  to  the  18S  and  28S 
RNAs found  in the completed ribosomes. 
DRB  was  chosen  for detailed  examination  be- 
cause  its  structure  would  not  permit  it  to  be 
inserted  into  the  rRNA  via  the  normal  RNA 
polymerase base pairing mechanism; it was, there- 
fore,  probably  interfering  with  ribosome  produc- 
tion by a  mechanism different than that suggested 
for toyocamycin (29).  Early work with this inhibi- 
tor  demonstrated  that  DRB was  able to decrease 
total  cellular  RNA  labeling (3).  Later  studies  by 
Egyhazi  et  al.  (7)  in  Diptera  salivary  glands 
indicated that DRB inhibited both rRNA synthesis 
and  HnRNA  synthesis.  In  this  paper,  we extend 
these studies with DRB to cover all types of RNA 
synthesis  and  investigate the disruption  in  rRNA 
synthesis and  processing  in more detail. 
In  the  accompanying  paper  (9)  I  discuss  light 
microscope studies  on  the  process  of NN  forma- 
tion  and  attempt  to  correlate  them  with  the 
biochemical data. 
MATERIALS  AND  METHODS 
Cell Culture 
A chick embryo fibroblast cell inoculum was prepared 
as described by Granick (9). Approximately 5 x  10  ~ cells 
were inoculated when the cells were to be grown on cover 
slips in vials containing  1.0 ml medium. When the cells 
were to be grown in 100-mm Falcon tissue culture dishes 
containing  l0  ml  medium,  1.0-2.0  x  l07  cells  were 
inoculated.  The  cultures  were  maintained  at  37~  in 
Eagle's minimal essential medium containing  10% fetal 
bovine  serum.  The  medium  was  changed  1 day  after 
inoculation  of the cultures  and  every other day  subse- 
quently.  Biochemical experiments were generally carried 
out with  2- or 3-day  cultures (approximately  107 cells/ 
dish). 
Primary  chick  embryo  liver cell cultures  were  pre- 
pared according to the method of Granick (10) and were 
grown  in  Ham's  medium  containing  10%  fetal bovine 
serum. 
Chemicals 
DRB and  MPB were gifts from the Merck Chemical 
Div., Merck & Co., Inc.,  Rahway, N. J. 5-Bromotuber- 
cidin  was  a  gift from  Dr.  B.  Brdar  of The Rockefeller 
University, New York. Toyocamycin was a gift from Dr. 
R.  J.  Suhadolnik,  Albert  Einstein  Medical  Center, 
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Wieland  of the  Max-Planck-Institut,  Heidelberg,  Ger- 
many.  [5-3H]Uridine  and  L-[l-~4C]leucine  were  pur- 
chased  from the New  England Nuclear  Boston,  Mass. 
Ethylene diacrylate was purchased from the Monomer- 
Polymer Div.,  Bordon Chemical Div.,  Philadelphia, Pa. 
Seakem agarose is distributed by Bausch and Lomb Inc., 
Rochester, N. Y. 
RNA Isolation 
The RNA isolation was essentially that of Tiollais et 
al. (31) which was a modification of the one devised by 
Scherrer and Darnell (23). We scaled down the procedure 
to  handle CEF  cells  from  two  100-mm  tissue  culture 
dishes,  or  approximately  1.2-4.0  ￿  107  cells  with  a 
packed  cell  volume  of  0.1-0.2  ml.  Volumes  of  the 
solutions were selected so that narrow 3.0-ml test tubes ( 1 
￿  7.5 cm) could be used for centrifugation of the phenol 
emulsion. After the first phenol extraction, the aqueous 
phase was transferred to a  new 3-ml test tube and the 
phenol extraction was repeated twice by adding 0.5 vol of 
phenol  solution,  covering  the  test  tube  tightly  with 
Parafilm, and shaking it at 5~  for 15 min. Two ethanol 
purification steps were used and the final RNA precipi- 
tate was  redissolved in the smallest possible volume of 
glycerol electrophoresis buffer. 
Gel Electrophoresis 
The RNA samples were electrophoresed on composite 
acrylamide-agarose  gels  similar to  those developed  by 
Peacock  and  Dingman  (19).  We  substituted  ethylene 
diacrylate for the bisacrylamide for easier hydrolysis (4) 
and modified the concentrations of various components 
to get better slicing characteristics in an egg slicer-type 
gel slicer.  The gels were  made with the electrophoresis 
buffer of Weinberg et al. (34).  The preparation of this 
modified  gel  solution  has  been described  in detail  by 
Granick (8). Quartz gel tubes (0.7 cm inside diameter ￿ 
10.0 cm in length) were used.  In order to form flat upper 
gel surfaces, cylindrical plastic plugs (about 0.65  cm in 
diameter) scored with two vertical grooves on their sides 
were allowed to sink  1.5 cm into the gel-filled tubes. A 
small rubber band around the plug prevented the plugs 
from slipping farther. The RNA samples were dissolved 
in electrophoresis buffer containing  15% glycerol (vol/ 
vol)  and  were  electrophoresed  at  5  mA/gel  (approxi- 
mately 40 V) as described by Weinberg et al. (34). In this 
paper all RNA samples were electrophoresed for 6 h at 
room temperature. 
Gel Scanning and Quantitation 
The  optical  density  of  the  gets  was  determined  by 
scanning them directly inside their quartz tubes at 260 
nm with a  specially designed motorized gel holder in a 
Cary  no.  14 spectrophotometer. Three blank gels were 
run to determine an average base line for the OD curves. 
To determine the cpm of the gels,  they were sliced  in 
an  egg  slicer-type  gel  slicer  (0.91  ram/slice)  and  two 
slices were added per scintillation vial. Soluene (Packard 
Instrument Co.,  Inc., Downers Grove, i11.) (0.7  ml) was 
added to each vial and the vials were tightly closed with 
plastic  lined  caps  and  incubated  at  60~  for  2  3  h. 
Toluene-Omnifluor (New England Nuclear) (10 ml) and 
0.05  ml of absolute ethanol were then added. The vials 
were counted in a  Packard scintillation counter. 
The cpm curves for a series of gels were normalized to 
equal amounts of RNA sample per gel by using the 18S 
cytoplasmic  rRNA  peak  from  the  gel  optical  density 
scans as a measure of cell number. 
EXPERIMENTAL  PROCEDURES 
Effects  of NN-Forming Chemicals 
on Total Cellular RNA and 
Total Protein Synthesis 
The  effects  of  NN-forming  chemicals  were 
investigated in a  series of vial labeling experiments 
(Fig.  l).  CEF  cells  were  grown  as  monolayer 
cultures  on  cover slips in vials containing Eagle's 
medium.  DRB  or  adenosine  was  added  to  the 
medium at concentrations which had been found to 
produce  good  NN  formation  as  seen  by  micro- 
scope examination (9). Then [3H]uridine or [~4C]- 
leucine  was  added  and  the  cells  were  harvested 
after  increasing  periods  of time.  The  cover  slips 
were  then  fixed  in  glutaraldehyde,  washed,  and 
their cpm determined. 
The NN-forming chemicals were seen to greatly 
inhibit [aH]uridine incorporation (Fig.  1 a) but to 
have  little  effect  on  [14C]leucine  incorporation 
(Fig.  1 b)  for  at  least  a  2-h  period.  Only  a  small 
decrease  in  protein  synthesis  (10-20%)  was  ob- 
served after 4 h of [l'C]leucine incorporation in the 
presence  of  the  NN-forming  chemicals.  Similar 
results  have  been  reported  for  toyocamycin  (29) 
and for bromotubercidin (2). 
Effect of  NN-Forming Chemicals 
on the Rate of Uridine Uptake 
by the Cells 
Most of the NN-forming chemicals are nucleo- 
sides or nucleoside analogues. Some of these, such 
as MPB or high concentrations of adenosine, have 
been  reported  to  be  competitive  inhibitors  of 
nucleoside uptake into the cell (18, 26, 28). For this 
reason  any  decrease  in  [aH]uridine  incorporation 
observed  in  the  presence  of  these  inhibitors  will 
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FIGURE  1  Inhibition of total RNA synthesis and non- 
inhibition  of  overall  protein  synthesis  by  DRB  and 
adenosine. A  separate experiment with its own control 
was used for each compound. (a) [3H]uridine incorpora- 
tion. (b) [l~C]leucine incorporation. O  O, control for 
DRB experiment; A  A, control for adenosine experi- 
ment; m  g, DRB (50 tzg/ml); ￿9  ￿9  adenosine (2 
mM).  For  DRB:  Vials containing monolayers  of cells 
growing on cover slips were preincubated for 30 min with 
50 #g/ml  DRB  per ml  of medium.  At zero time,  one 
series of vials received [SH]uridine (1.0 #Ci/ml medium 
and a final concentration of 0.3 #M) and a second series 
of vials received [l~C]leucine  (0.25 zCi/ml medium and a 
final concentration of 0.87 #M). The control cell series 
were given the same amounts of label but no DRB. For 
adenosine: Both adenosine and labeled compounds were 
given together at zero time. One series of vials received 
adenosine to a final concentration of 2 mM and [SH]uri- 
dine (1.0 or 2.0 zCi/ml medium and a final concentration 
of 0.12 or 0.24/zM) and a second series of vials received 
adenosine (2  mM)  and  [l~C]leucine (0.5  or  1.0  Ci/ml 
medium and a final concentration of 2 or 4 #M). Control 
vials  received  the  same  concentration of  label  but  no 
adenosine. Labeling was stopped at the indicated times 
by placing the  vials in an  ice  bath. The cover slips of 
labeled cells were washed in their vials with three changes 
of ice-cold Earle's solution and were fixed  for 10 rain in 
2.5%  glutaraldehyde 0.1  M  phosphate  buffer,  pH  7.4. 
They were then washed with several changes of physio- 
logical  saline  over  the  next  1-2  h  to  remove  small 
radioactive  molecules  which  might  have  been  trapped 
inside the cells.  After dipping the cover slips in distilled 
reflect both a decreased rate of RNA synthesis and 
a decreased rate of [3H]uridine uptake into the cell. 
Therefore, to determine the actual effect of an NN 
inhibitor  on  the  rate  of  RNA  synthesis,  it  is 
necessary to determine a  correction factor for the 
inhibition of [3H]uridine transport. 
The correction f~ictor for the inhibition of [3H]- 
uridine uptake was obtained in a  vial-labeling ex- 
periment by comparing the amount of [3H]uridine 
found  inside  the  cells  in  the  presence  and  ab- 
sence  of each  inhibitor (Fig.  2).  In  one  series  of 
vials,  cells  growing  on  cover  slips  were  labeled, 
then  fixed  in  glutaraldehyde,  and  extensively 
washed  so  that  all  the  soluble  nucleotides  were 
removed.  The  cpm  remaining  on  the  cover  slips 
represented  [3H]uridine  fixed  into  the  cellular 
RNA.  In a  second series of vials the cover slips of 
labeled  cells  were  washed  with  medium,  just  to 
remove  contaminating  nucleosides  from  the  cell 
surface,  and  were  then  air  dried  so  that  the 
acid-soluble  pool  of  nucleotides  remained  inside 
the  cells.  These  cpm  represented  label  in  both 
"RNA"  +  "pool." A  subtraction of the cpm from 
these  two  vial  series  yielded  the  cpm  of  the 
[SH]uridine pool. 
Values  for  the  inhibition of uptake  of [3H]uri- 
dine  into the cell for various NN-forming  chemi- 
cals have been summarized in Table I. Adenosine, 
MPB, and DRB were found to inhibit [SH]uridine 
uptake but toyocamycin had no effect. 
Rate of Total RNA  Synthesis 
The  values  of [3H]uridine  incorporation  in  the 
presence  of  NN-forming  chemicals  were  then 
corrected to represent the actual rate of total RNA 
synthesis  (Table  I).  Toyocamycin  (2  tzg/ml)  and 
DRB  (50  vg/ml)  were  found  to  be  the  most 
efficient inhibitors of total RNA synthesis, depres- 
sing it to 40% of the control level. 
water,  they  were  air  dried.  They  were  digested  in 
scintillation vials with 0.5 ml Soluene at 60oC for 2 h. 
Toluene-Omnifluor was then added  and the vials were 
counted  in  a  Packard  scintillation counter.  Data  were 
plotted as cpm/#Ci/cover slip vs. time of incu6ation with 
label.  Each  point represented the average cpm of four 
cover slips.  The average deviation from this mean value 
was  •  I(~o. The cpm data for the adenosine experiment 
were scaled to those of the DRB experiment so that they 
could be plotted on the same graph. This was done by 
multiplying the adenosine cpm  by a  factor to superim- 
pose the control curves for the two sets of data. 
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FIGURE  2  Inhibition of [SH]uridine uptake and inhibition of total RNA synthesis by various NN-forming 
chemicals in CEF cells.  O  O, control; ￿9  ￿9  toyocamycin; I----I,  adenosine; ￿9  --~, DRB; 
[]  l-I,  MPB.  Two  series of vials,  one for  RNA  and  one for  RNA  +  pool,  were  assayed  for each 
inhibitor. Cover  slips,  with  approximately  one  layer  of CEF  cells growing  in  Eagle's  medium,  were 
preincubated with one of the following inhibitors for 30 rain: toyocamycin (TCM) (2/~g/ml); adenosine (2 
mM=  0.53 mg/ml); DRB (25 #g/ml); and MPB (25 #g/ml). Both series of vials then received the same 
concentration of [SH]aridine (2 #Ci/ml; 14 #M). A second experiment with DRB was done with 50 #g/ml 
DRB and concentrations of [SH]uridine similar to those used in the later gel  experiments.  In this vial 
experiment, the cells were preincubated for 30 rain with 50 #g/ml DRB. Vials from the RNA series were 
the given 4 #Ci/ml [aH]uridine; vials from the RNA +  pool series received 0.8 #Ci/ml [3H]uridine. Control 
cells received label only: 2 #Ci/ml for the RNA series; 0.4 #Ci/ml for the RNA +  pool series.  Although the 
concentration of [SH]uridine was varied, the total uridine concentration was kept at 0.16 #M by adding cold 
uridine. In all other respects this second DRB experiment was identical with the first. Vials were harvested 
at various times after addition of label (t  =  0) throughout a period of 3 h. The cover slips were washed, 
fixed, and counted as described in the legend to Fig. I. The resulting cpm were expressed as cpm/#Ci/cover 
slip.  All vials were  run in quadruplicate and the average deviation from the mean for these points was 
10%. The cpm/pCi/cover slip for the RNA vial series, the RNA +  pool vial series and their arithmetical 
difference or pool were plotted vs. time. 
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Ratio cpm inhibitor/control 
20 
"Uncorrected"  [SH]uridine  "'Corrected" 
[SH]uridine incorporated  uptake into  total RNA 
into RNA  cell pool  synthesis 
Adenosine  2 mM  14  0.15  0.33  0.5 I 
Toyocamycin  2/~g/ml  14  0.38  1.0  0.38 
MPB  25 #g/ml  14  0.44  0.65  0.68 
DRB  25/Lg/ml  14  0.33  0.65  0.51 
DRB  50/~g/ml  0.16  0.19  0.47  0.40 
DRB*  50 #g/ml  0.3  0.12  _  w 
These calculations were made with the cpm values obtained from Fig. 2. The "corrected" values for RNA synthesis 
were  obtained  by  dividing  the  "uncorrected"  RNA  ratios  by  the  [SH]uridine  uptake  ratio.  The  ratios  have an 
approximate error of +20%. 
* Indicates that the data were obtained from the experiment of Fig.  I. 
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TABLE  I 
Inhibition of [SH] Uridine Uptake and Corrected Total RNA Synthesis by NN-Forming Chemicals in CEF 
Cells 
O  I 
-20  O  *20  *60  *90  *120 
t 
DRB  Time(min) 
FIGURE  3  Rate  of onset of  DRB  inhibition of total 
RNA  synthesis. O  O,  control;  II~@,  DRB  25 
#g/ml; Z~  Z~, DRB 50 #g/ml. Vials of cells growing 
on  cover  slips  were  preincubated  with  [SH]uridine  (1 
/=Ci/ml; 0.04  u.M  final  medium  concentration)  for 20 
min.  Then  either  25  or  50  /~g/ml  DRB  in  aqueous 
solution  was  added  at  zero  time,  and  the  vials  were 
harvested at various times afterwards. Controls did not 
receive DRB. Cover slips of cells were washed,  fixed, and 
counted  as described  in  Materials and  Methods.  Data 
are  plotted  as cpm/#C~/coverslip vs.  time of labeling. 
Each  point  represents  the  average  of four cover slips, 
deviation from the mean being + 10%. 
DRB (50 #g/ml) Maximally Inhibited 
Total RNA  Synthesis  within a 
lO-15-Min Period 
This was determined by allowing vials with cells 
to incorporate [SH]uridine for 20 min, then adding 
50  /Lg/ml  DRB,  and  following  the  decrease  in 
[SH]uridine incorporation  into the cover slips over 
a  short  time  period  (Fig.  3).  This  rapid  action 
suggested  that  DRB  was  interfering directly with 
RNA synthesis. 
Inhibition  of HnRNA  Synthesis 
The  inhibition  of  HnRNA  synthesis  by  DRB 
was  demonstrated  indirectly  by  measuring  total 
cellular RNA labeling over a  short time period in 
the presence of low concentrations of actinomycin 
D.  This experiment  took  advantage of two obser- 
vations on cellular RNA synthesis: (a) After short 
labeling  periods  (1  h),  approximately  50%  of the 
[SH]uridine  label  is  found  in  the  HnRNA  and 
approximately  50%  is found  in the rRNA species 
(27). (b) Low concentrations of actinomycin selec- 
tively inhibit  rRNA  synthesis.  At  concentrations 
of actinomycin  which  inhibit  rRNA  synthesis  by 
80-90%,  other types of RNA synthesis are practi- 
cally unaffected (22). Therefore, in the presence of 
low concentrations of actinomycin, the [SH]uridine 
label, incorporated into total cellular RNA after a 
l-h  period,  will  be  essentially  that  incorporated 
into the HnRNA. 
This experiment (Fig. 4) was done in two stages. 
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FIGURE 4  The effect of DRB on total RNA synthesis when rRNA synthesis has been selectively inhibited 
with low concentrations of actinomycin D. CEF cells growing on cover slips in vials were given 0.025 or 0.1 
#g/ml of actinomycin D. Control cells received no actinomycin D. Some vials from each of these three 
groups  also  received  50  pg/ml  DRB.  After  30  rain  of preincubation  with  the  inhibitors,  1.0 ,Ci/ml 
[aH]uridine  (0.3 pM) was given and the cells were harvested over a period of 3.5 h. The cover slips of labeled 
cells  were washed,  fixed in glutaraldehyde,  and  counted as described  in  Fig.  1.  All points were done in 
quadruplicate and the average cpm of the four cover slips were plotted vs. time. The average deviation from 
the mean for these points was  + 10%. The DRB cpm were corrected for inhibition  of [3H]uridine  uptake 
(Table  l).  O  ￿9  control. The inset shows  the inhibition  of total cellular RNA synthesis  caused  by 
increasing  amounts of actinomycin D. The ceils were preincubated for 30 min with different concentrations 
of actinomycin. [sH]Uridine (2 pCi/ml; 0.04 pM) was then added  and the incubation was terminated after 
another  60  min  as  described  above.  The  average  cpm  per  cover  slips  were  plotted  vs.  actinomycin 
concentration. 
First,  the  inhibition  of  total  RNA  labeling  by 
increasing  concentrations  of  actinomycin  D  was 
determined for the CEF cells (inset,  Fig. 4).  From 
these  data  two  actinomycin  D  concentrations 
(0.025  and  0.1  ,g/ml)  were  chosen.  Then  both 
DRB (50 pg/m|) and actinomycin D (0.025  or 0.1 
pg/ml)  were given simultaneously,  30 min before 
the  addition  of  [aH]uridine  (Fig.  4).  Even  at  the 
lowest  concentration  of  actinomycin  D,  DRB 
caused an almost complete cessation (95%) of total 
cellular RNA  synthesis.  One can  conclude there- 
fore  that  DRB  is  a  very  effective  inhibitor  of 
HnRNA  synthesis.  Labeling experiments  in  Dip- 
tera  salivary  glands  strongly  support  the  conclu- 
sion  that  HnRNA  synthesis  is almost completely 
inhibited by DR8 (7}. 
Synthesis of tRNA 
The  synthesis of tRNA was only slightly inhib- 
ited (20%) by DRB (50 pg/ml) over a 3-h period as 
shown by RNA labeling and gel electrophoresis of 
the  tRNA  (for experimental details  see reference 
8). 
Extensive Inhibition of mR NA Synthesis 
by NN-Forming Chemicals 
This  was  suggested  by  experiments  in  chick 
embryo liver cells which showed that the synthesis 
of the enzyme A-aminolevulinic acid  (ALA) syn- 
thetase  was  inhibited  to  the same extent  by  NN- 
forming chemicals as it was by high concentrations 
of actinomycin D. ALA synthetase is the first and 
rate-limiting enzyme of the porphyrin biosynthetic 
pathway.  The enzyme is relatively short lived with 
a  half-life  of  about  3  h  and  its  mRNA  has  a 
half-life of 4-6 h  (10). 
In  whole cells, ALA synthetase  activity can  be 
assayed  indirectly  by  measuring  the  fluorescence 
of the porphyrins  generated  from  ALA (12).  This 
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embryo liver cells grown  on a  cover slip in  a  vial 
(0.1  mg protein/cover slip).  In the presence of the 
inducer,  allylisopropylacetamide  (AIA),  the  level 
of ALA synthetase is increased  10- to 20-fold over 
the  normal  basal  level.  The  difference  between 
these levels can be made even greater by addition 
of the  iron  chelating agent desferrioximine  along 
with  the  AIA  and  by  growing  the  cells  in  a 
modified  Ham  FI2  medium  containing  insulin 
instead of a Ham-fetal bovine serum medium (24). 
Over a  5-h period,  if mRNA  synthesis has been 
stopped by a certain concentration of an adenosine 
analogue,  the  assay  will  show  lower  levels  of 
enzyme activity than if mRNA  synthesis has been 
TABLE  I1 
Inhibition  of  ALA  Synthetase  Production  in 
Chick Emb(vo Liver Cells by NN-Forming 
Chemicals  and Other lnhibitors 
Protoporphyrin 
Inhibitor  per cover slip. 
Inhibitor  concn  % control 
lag/ml 
Control  100 
Acetoxycycloheximide  0.6-0.2  I  0 
Actinomycin  0.25  50* 
a-Amanitin  2  20  55 
Cordycepin  3  35 
(Y-deoxyadenosine) 
DRB  5  20  45 
DRB  50  30 
Toyocamycin  0.5  2.0  50 
Toyocamycin  4.0  40 
Bromotubercidin  0.5  4.0  55 
Adenosine  100  500  50 
Guanosine  100  300  40* 
Adenosine + guanosine  100 +  100  40* 
Acetoxycycloheximide  0.2}  10 
+ DRB  50 
Chick embryo liver cells were grown in a monolayer in vials on 
cover slips in 1 ml of modified Ham's medium +  10% fetal bovine 
serum for 24 h; the medium was changed to Ham's  +  insulin 
(0.25 #g/ml) and desferrioximine  (500 ,u.g/ml). and the cells were 
allowed to grow 2 h more. At zero time of the experitnent, the 
medium  was  replaced  by  I  ml  of  the  Ham  +  insulin  + 
desferrioximine medium and the inducing chemical AIA  (300 
#g/ml) and the various inhibitors were added. At this time the 
cells were not multiplying. After 5 h, the medium was removed 
and the porphyrins were extracted from the cover slips of cells 
with 1 N perchloric acid, methanol ( I : I ). The porphyrin extracts 
were then assayed fluorimetrically (8). Control cells, given only 
AIA and desferrioximine, contained 22.2 •  1.6 pmol protopor- 
phyrine/cover  slip (the  cover slips contained  about  0.1  mg 
protein). The vials were run in quadruplicate and. the average 
deviation from the mean was •  15%. 
* Indicates that the value was determined in a second experiment. 
occurring during this time. The inhibition of ALA 
synthetase  production  by  various  inhibitors  is 
summarized  in  Table  II.  The  protein  synthesis 
inhibitor  acetoxycycloheximide  completely 
stopped the synthesis of new enzyme.  In contrast, 
inhibitors known to  block mRNA  synthesis, such 
as  actinomycin  (0.25  #g/ml)  and  a-amanitin  (2 
~g/ml), decreased the ALA synthetase activity by 
only  50%  during  the  5-h  period.  This  50%  level 
represents  enzyme  synthesized  from  the  mRNA 
already  present  in  the  polysomes  at  the  time  of 
inhibitor addition. Cordycepin (3 ~tg/ml) appeared 
to decrease the enzyme levels even further but this 
may have been due to some cell damage. 
DRB at concentrations of 5  20 ~zg/ml inhibited 
porphyrin synthesis about 55%, or about the same 
as  seen  with  0.25  ~tg/ml  actinomycin,  suggesting 
that  the  inhibition by  DRB  was  probably  occur- 
ring at the transcription or posttranscription level. 
Increasing DRB up to 50 ~tg/ml inhibited porphy- 
rin synthesis 70%; this additional inhibition might 
have been due to  inhibition of ALA  synthetase at 
the translational level. 
A  control  experiment  demonstrated  that  DRB 
(50 ~tg/ml) did not interfere with the conversion of 
ALA  to  porphyrin,  therefore  a  decrease  in  por- 
phyrin formation reflected a decrease in ALA-syn- 
thetase activity. 
The other NN-forming chemicals, toyocamycin, 
bromotubercidin,  and  adenosine  also  inhibited 
ALA-synthetase activity by 50-60%. 
A  more detailed comparison between the effects 
of  actinomycin  D  and  DRB  on  ALA-synthetase 
production  was  made  to  confirm  the  possibility 
that  NN-forming  chemicals  were  completely  in- 
hibiting  mRNA  synthesis.  The  procedure  was 
similar to  that  in  the  previous experiment except 
that the time of addition of inhibitor and inducing 
chemicals  was  varied.  Actinomycin  (0.25  or  0.5 
~tg/ml)  or  DRB  (25  or  40  ~tg/ml)  was  given  2  h 
before,  simultaneously  with,  or  2  h  after  the 
inducing  chemical  AIA.  The  experimental  plan 
and  data  are  detailed  in  my  thesis  (8).  Here  I 
summarize the experimental results. 
DRB  (25  /ag/ml)  was  found  to  inhibit  ALA 
synthetase  production  to  the  same  degree  as  0.5 
~tg/ml  actinomycin.  As  expected,  the  inhibitors 
were  most effective when added  before the induc- 
ing chemicals.  The  close  correspondence between 
the action of the two  inhibitors added  at different 
times  with  respect  to  the  inducing chemical  AIA 
over a  4-h period strongly supports the hypothesis 
that  DRB  and actinomycin were  acting similarly, 
probably to completely  inhibit mRNA  synthesis. 
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FmURE 5  Inhibition of rRNA synthesis  and processing  by DRB.  Radioactivity determined at the end 
of 3 h of continuous labeling with [SH]uridine.  CEF cells were grown in  100-mm diameter tissue culture 
dishes to a cell density of approximately 1-2 x  i0  T  cells/plate. Two plates were used per point.  They were 
allowed to equilibrate for I h with 5 ml fresh Eagle's medium and were then preincubated for 30 min with 50 
~g/ml DRB before addition of 4.0 uCi/ml [SH]uridine.  Cold uridine was added to make the final uridine 
concentration 0.3  tAM. (The  addition  of cold uridine  does  not affect the conclusions drawn  from this 
experiment.) Control cells were given 1.0 t~Ci/ml [aH]uridine  (final uridine concentration 0.3 tzM). The cells 
were  allowed  to  incorporate  label  for  3  h.  After  harvesting  the  cells,  the  RNA  was  isolated  and 
electrophoresed on 2.5% acrylamide-0.6%  agarose gels. The gels were scanned  at 260 nm and were then 
sliced,  their cpm determined  and  the cpm values normalized to equal [SHjuridine  concentration in the 
medium (2.0 ~Ci/ml) and to equal RNA sample size (using the 18S OD peak as described in the text). The 
DRB cpm were corrected for inhibition of uridine uptake by DRB (Table I). The large OD peak (dashed 
curve) seen to the left of the 45S RNA peak, i.e., closer to the top of the gel, is actually DNA because it is 
heavily labeled when the CEF cells are exposed to [SH]thymidine  for a  l-h period (D. Granick, unpublished 
observations).  (45S  RNA cpm measured before any correction factors were applied:  DRB  =  1.9 ￿  104, 
controls =  4.3  ￿  10s.) -  -  -  OD 260 rim; A  A cpm, control cells; @------@ cpm, DRB cells. 
rRNA Synthesis 
The  effect  of  DRB  and  other  NN-forming 
chemicals on rRNA production was examined in a 
series of gel experiments.  Studies on the action of 
two  of  these  chemicals,  toyocamycin  (29)  and 
bromotubercidin  (2),  had  already  demonstrated 
that  synthesis  of  the  45S  precursor  rRNA  was 
partly  inhibited  and  that  the  subsequent  rRNA 
processing steps were almost completely blocked. 
We  undertook  similar  types  of experiments  with 
toyocamycin  and  other  NN-forming  chemicals 
using the CEF cell system. 
In these experiments labeled RNA was isolated 
from whole cells, allowing all of the rRNA species, 
both nuclear and  cytoplasmic,  to be separated  on 
the  same  gel.  This  procedure  had  two  major 
advantages: (a) Degradation of any rRNA species, 
especially during the later stages of the processing 
sequence (e.g.,  32S to 28S  RNA), could be quan- 
titated more precisely than if nuclear and cytoplas- 
mic  RNA  fractions  were  assayed  separately.  (b) 
During a labeling experiment, results from a series 
of gels could  be  normalized,  using  the  18S  cyto- 
plasmic  rRNA  peak  from  the gel optical density 
scans  as  a  measure  of  cell  number.  Such  a 
correction  assumes  a  constant  cytoplasmic  ribo- 
some content  which  is approximately  true  for an 
experimental period of 3 h or less2 This procedure 
eliminated the necessity of tedious double-labeling 
experiments  used  by  other  authors  to  scale  their 
data to constant  amounts  of RNA recovery. 
Comparison of the rRNA  Gel Patterns 
Produced by NN-Forming Chemicals 
The  effect  of  five  NN-forming  chemicals  on 
rRNA  synthesis  and  processing  was  examined 
during  a  3-h  period  of labeling  with  [SH]uridine. 
Concentrations of the NN-forming chemicals were 
s The  RNA of these CEF monolayer cultures  doubles 
every 36 h. Therefore the amount of rRNA synthesized 
in a 3-h period is less than  10% of the total cellular RNA 
or within  the other experimental errors of the system. 
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formation  in  CEF  cells  as  seen  by  microscope 
examination. In Fig. 5, the cpm and OD gel scans 
are  shown  for  CEF  cells  treated  with  DRB  (50 
jzg/ml). Cpm gel scans are presented in Fig. 6 for 
CEF  cells  treated  with  toyocamycin (2  #g/ml), 
MPB (25 #g/ml), a-amanitin  (20 ug/ml), or 2 mM 
adenosine  (0.53  mg/ml).  All  cpm  curves  were 
normalized to equal RNA sample size (using the 
18S OD peaks of the gels as a reference) and were 
corrected  for  inhibition of  [3H]uridine  uptake, 
using the factors of Table I. 
In the control curves of Figs. 5 and 6, by the end 
of  a  3-h  labeling  period  with  [SH]uridine,  the 
labeling  in  the  45S  RNA  peak  had  reached  a 
steady-state level (as shown by Fig. 8 b), a slightly 
smaller peak  of labeled intermediate 32S  RNA 
was present, and large peaks of completely proc- 
essed  [SH]uridine  18S  and 28S  rRNAs were  evi- 
dent. 
In contrast, when NN-forming chemicals were 
present  during  the  3-h  labeling period,  marked 
changes from the control curves were noted (Figs. 
5,  6). (a) In all inhibitor-treated cells,  the sum of 
the cpm in the (32S +  28S) RNA peaks was much 
less  than  the  cpm  of  the  18S  peak;  this  fact 
suggested  that  extensive degradation  of the  32S 
and 28S  species  had  occurred. (b) The decreased 
size of the 45S RNA and 18S RNA peaks in Fig. 6 
suggested that there had been a decreased rate of 
45S RNA synthesis and that a steady-state in the 
labeling of the 45S  RNA  pool had  probably not 
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FIGURE  6  Inhibition of rRNA synthesis and processing by the NN-forming chemicals toyocamycin, 
adenosine, MPB, and a-amanitin. Procedure was the same as in Fig. 6. The CEF cells received one of the 
inhibitors to  make the following concentrations: adenosine (2 mM=  0.53 mg/ml),  MPB (25 #g/ml), 
toyocamycin (2 ~g/ml).  30 min later,  all plates then  received 4.0 #Ci/ml of [SH]uridine (sp act 27.8 
Ci/mmol; final concentration = 0.IM  #M; no cold uridine was added), ct-Amanitin  (20 #g/ml) was given  4 h 
before addition of 4.0 #Ci/ml uridine. Control cells also received 4.0 #Ci/ml [SH]uridine.  All plates were 
labeled for 3 h. Gel cpm were corrected to equal RNA sample size and for inhibition of uridine uptake 
(Table I) as described in the text. (45S RNA cpm before any correction factors were applied (￿  103): 
adenosine = 4.8, toyocamycin = 2.6, MPB = 2.0, ct-amanitin = 6.2, control = 26.) 
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RNA  peak  was  higher  than  in  the  control  cells, 
suggesting that  this inhibitor caused  an alteration 
in  the  normal  balance  of the  rates  of 45S  RNA 
synthesis and  processing. 
Action of DRB on rRNA  Synthesis and 
Processing with  Time 
To  attempt  to  analyze  more  fully  the  various 
changes  that  were  revealed  by  the  above  experi- 
ments,  a  time  study  of  rRNA  labeling  in  the 
presence  of  DRB  was  undertaken  (Fig.  7).  The 
CEF cells were continuously labeled with [3H]uri- 
dine in the presence of DRB (50 tzg/ml) for periods 
of time  up  to  7  h.  The  cpm  for  each  individual 
rRNA species was estimated from the gel curves of 
Fig. 7, and some of these cpm were plotted vs. time 
in  Fig. 8. 
From  these  data  four  major  conclusions  were 
derived: (a)  In the presence of DRB, the recovery 
of labeled 32S and 28S rRNA species was greatly 
(75-80%)  decreased.  To quantitate  the loss of the 
32S and 28S RNA, the assumption was made that 
the  accompanying  labeled  18S  RNA  was  not 
degraded;  this  approximation  was confirmed in a 
later experiment (Fig. 9; Table III). The extent of 
loss was then  calculated  from the molecular ratio 
(32S  +  28S)/18S  of  the  labeled  RNA  species 
recovered  from  each  gel.  A  number  proportional 
to  the  number  of  these  rRNA  molecules  was 
calculated by dividing the [aH]uridine cpm of each 
chick rRNA  species by its molecular weight (21). 
The  (32S  +  28S)/18S  ratio  was  nearly  1.0 for 
the control cells (confirming that the recoveries of 
the rRNA species on the gel and base-line correc- 
tion for the gel were good). However, this ratio was 
only 0.25  to 0.20  after 5-7 h  labeling in the pres- 
ence of DRB.  These data  suggest that  when  45S 
RNA is labeled in the presence of DRB and is then 
processed  in the presence of DRB, 75-80%  of the 
resulting  32S  and  28S  RNA  species  are  lost 
(perhaps  to undetectable  fragments). 
This  loss  of the  32S  and  28S  RNA  species  is 
reflected in Fig. 8 a  which shows the total increase 
in  rRNA  cpm  with  time.  The  increase  in  rRNA 
cpm  is  linear  for  the  control  cells,  but  gradually 
drops  off with the DRB-treated cells. 
(b)  In the presence of DRB, 45S RNA accumu- 
lates  at half the control cell rate.  The rate of 45S 
RNA synthesis was assumed to be proportional to 
the  increase  in  total  rRNA  cpm  (Pig.  8  a)  after 
correction had  been  made for the loss of 32S  and 
28S  RNA cpm. The cpm of the degraded  (32S  + 
28S)  RNA  were  estimated  by  calculating  the 
theoretical yield of 28S  RNA from the measured 
18S RNA cpm multiplied by the molecular weight 
ratios  of  the  28S  and  18S  RNA  species.  When 
these lost cpm were added back to the total rRNA 
cpm  measured  for the  DRB ceils (dotted  circles, 
Fig.  8  a),  the  buildup  of total  rRNA  cpm  was 
found to be nearly linear and  proceeded at a  rate 
approximately  50%  of  the  rate  observed  in  the 
control  cells.  (The  initial  rate  of  45S  rRNA 
accumulation can also be approximated  from Fig. 
8 b, but such a calculation is less accurate because 
the early time points are the least accurate of this 
experiment.) 
(c) In DRB-treated cells, the rate of appearance 
of labeled  18S rRNA products was half that found 
in  the control  cells (Fig.  8  c), in  parallel with the 
50% decrease in 45S  rRNA accumulation. 
(d)  In  DRB-treated  cells  the  cpm  in  the  45S 
rRNA  pool, during  a  6-h exposure to DRB, built 
FIGURE  7  Inhibition  of 45S  RNA  synthesis  and  processing  by  DRB:  7-h  continuous  labeling  with 
[SH]uridine.  (a-c) Radioactivity of DRB-treated cells: (a) .....  20 min. O  O  1 h, ~  3 h; (b) 
O  O  5 h, 0---------0 6 h; (c) O  O7 h, Optical density of DRB cells ---, 7 hr. (d, e) Radioactivity of 
control cells: (d) A  A 20 min, ￿9  ￿9  1 h; (e) A  -  A  2 h, ￿9  ￿9  3 h. The experimental procedure 
was similar to that described  for Fig. 5. Cells were grown to approximately  1.2 ￿  107 cells per 100-mm 
plate. Plates containing 5 ml of Eagle's medium were preincubated for 30 min with 50 #g/ml DRB given as 
a dimethylsulfoxide solution (50 ~g DRB/~I DMSO). Controls received DMSO only. [3H]Uridine was then 
added.  DRB cells received 2 or 4 ~Ci/ml of [SH]uridine;  control cells received 1 or 2 ~Ci/ml. The final 
uridine  concentration for all plates was brought up to 0.3 ~M by the addition of cold uridine.  Plates were 
then harvested over a period of 7 h. Two plates were used per point. RNA was extracted, separated by gel 
electrophoresis, and the OD and cpm curves for each gel were determined. The cpm curves for each gel were 
normalized to equal [SH]uridine concentration in the medium (2.0 ~Ci/ml), to equal RNA sample size, and 
the DRB cpm were corrected for inhibition of uridine uptake by DRB (Table I) as described in the text. (A 
correction for increased cytoplasmic 18S RNA content after 7 h of growth was not considered necessary  for 
the DRB-trcated cells since they make 18S RNA at only half the rate of the control cells) 
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FIGURE 8  Changes  in the cpm of various rRNA species during continuous [SH]uridine  labeling in the 
presence of DRB. Measured cpm: C)  O control cells, -~  ￿9  DRB cells. The cpm of the individual 
rRNA species were estimated from the gel curves of Fig. 8. (a) Nonlinear increase in total rRNA cpm in 
the presence of DRB due to the degradation of 32S +  28S RNA. When the cpm of the degraded 32S + 
28S RNA is calculated (see text) and added back to the total rRNA cpm of the DRB cells, a straight line 
(- -O- -) is obtained. (b) Accumulation of 45S RNA cpm. (c) Inhibition of 18S RNA cpm appearance. 
up and leveled off to a value about twofold higher 
than that seen in the control cells (Fig. 8 b). 
Tests of Mechanisms for Degradation  of 
32S and 28S RNA  Preribosomes 
There  were  two  possible explanations for  the 
loss of the 32S and 28S rRNA preribosomes seen 
in  the  presence  of  DRB:  (a)  A  normal  45S 
rRNA-containing  preribosome  was  made  and 
DRB  interfered with the function or synthesis of 
the  enzyme(s) which  normally process  it to  32S 
and 28S RNA. (b) DRB caused the formation of a 
defective 45S rRNA preribosome which could not 
be processed properly; but the processing mecha- 
nism  itself  was  unaffected  by  DRB  and  could 
convert normal 45S rRNA into normal products 
even in the presence of DRB. These two possibili- 
ties  were  distinguished  by  using  a  pulse-chase 
experiment. 
Methionine Pulse-Chase  Experiment 
PROCESSING  OF  45s  rRNA  SYNTHESIZED 
IN  THE  PRESENCE  OF  DRB:  After  30  min of 
preincubation with DRB (50 ~tg/ml), CEF cell 45S 
rRNA was labeled in the presence of DRB for a 
30-min period  with  [methyl:H]methionine. The 
radioactive medium was then replaced with fresh 
medium containing a large excess  of cold methio- 
nine as chase.  The processing of the labeled 45S 
rRNA  was  followed  with  time during the  chase 
period. Cpm gel curves are presented in Fig. 9. The 
cpm  of the  individual rRNA  species  were  esti- 
mated and plotted vs. time of chase (Fig.  10). All 
cpm curves were normalized to equal RNA sample 
size  (using the  18S  OD  peaks  as  reference).  A 
correction for [3H]methionine uptake into the cell 
in  the  presence  of  DRB  was  unnecessary since 
DRB  does  not  seem  to  appreciably  affect  the 
transport of amino acids (Fig.  1).  For short-time 
rRNA  labeling experiments, [3H]methyl labeling 
gives more accurate results than [3H]uridine label- 
ing (14). 
From Figs. 9 and  10 a, it can be observed that 
the total rRNA methyl cpm decreased during the 
chase period in both the DRB-treated ceils and the 
control cells. Theoretically, the number of rRNA 
methyl groups should remain constant during the 
processing.  A  slow  loss  in  methyl  label  was 
observed for the control cells.  In the DRB-treated 
cells the degradation of total rRNA methyl cpm 
was much more pronounced. 
32s  AND  28S  rRNA:  The  extensive loss  of 
32S and 28S rRNA cpm in the DRB-treated CEF 
cells  during the  chase  period  is  demonstrated in 
Figs. 9 a  and 10 e. The extent of degradation was 
quantitated by calculating the.cpm ratios of (32S 
+  28S)  RNA  recovered  to  the  amount  of  18S 
RNA produced during the chase. Table III com- 
pares these calculated cpm ratios to the theoretical 
[3H]methyl ratios calculated from the  HeLa  cell 
data of Weinberg and Penman (35).  The data in 
Table III indicate that when 45S RNA which was 
synthesized in the presence of DRB  is processed 
after  DRB  is  removed,  75-80%  of the  resulting 
(32S  +  28S) RNA is lost. 
18s  rRNA:  In contrast, there was only a slight 
loss  (approximately  20%) of  18S  rRNA  in  the 
DRB-treated  cells.  This  loss  in  18S  cpm  was 
reflected  in  the  AI8S/A45S  ratio  of Table  ii1, 
which  compares the  amount of  18S produced to 
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FIGUgE 9  Processing of  [3H]mcthyl-labcled  "DRB  45S  RNA"  after  removal  of  the  inhibitor.  (a) 
Processing of DR B 45S RNA. Time of chase: --- 0 rain,  30 min, --..--  1 h,  2 h. (b) Processing 
of normal 45S RNA. Time of chase: -  -  - 0 rain, --..--  30 rain, --  1 h. Cells were grown to a monolayer 
density of approximately  l0  t  cells per  100-ram  diameter plate. The medium was then changed to 5 ml 
Eagle's medium minus methionine and supplemented with 0.02 mM adenosine and 0.02 mM guanosine to 
prevent use of the methyl label during purine biosynthesis (14). Cells to be inhibited were given 50 ~g/ml of 
DRB in 5 p.l of DMSO. Control cells received 5 #1 of DMSO only. After 30 min of incubation at 37~ 
[methyl-aH]methionine  (6  izCi/ml;  sp  act  4  Ci/mmol)  was  added  and  the  cells were  returned  to  the 
incubator for a 30-rain labeling period. The radioactive medium containing DRB was then replaced with 
10  ml  of the  frash  Eagle's  medium  containing 0.1  mg/ml  of cold  methionine (500-fold  the  original 
[aH]methionine concentration). Cells were harvested from the plates immediately after the medium change 
as a "zero time" sample. Other plates were harvested after 30 min, 1 h, and 2 h of chase. Two plates were 
used per point. RNA was extracted and separated by gel electrophoresis and the cpm data were normalized 
to equal sample size (see text). 
that  of  the  45S  RNA  which  disappeared.  The 
increase in this ratio with time suggests that there 
may have been some delay in the processing of an 
intermediate species (20S?) into the completed  18S 
molecules. 
The  loss  of  32S  and  28S  rRNA  in  the  DRB- 
treated  cells suggested  that extensive degradation 
of  the  DRB  preribosomes  was  occurring.  It  is 
probable  that  this  degradation  occurred  before 
completed  32S  rRNA-containing  preribosomes 
appeared  in  the  45S  to  32S  rRNA  processing 
sequence.  This  has  been  concluded  because  the 
fraction  of the  total  cpm  which  entered  the  32S 
rRNA  pool was never as high in the DRB-treated 
cells  as  it  was  in  the  control  cells  (Fig.  10 yO. 
However, one cannot eliminate the possibility that 
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FIGURE l0  Changes in the cpm of various rRNA  species  during the processing of [3H]methyl-labeled 
DRB 45S RNA after the inhibitor has been removed. O  O  control cells,  normal labeled 45S RNA; 
DRB cells,  45S RNA labeled in the presence of DRB. The cpm of the individual rRNA species 
were estimated from the gel curves of Fig. 9 and were plotted against time of the cold methionine chase. (a) 
Total rRNA cpm present in the gel. (b) cpm of the 45S RNA peak. Inset shows log plot of these data with a 
graphic determination of the half-life of the 45S RNA. (c) 18S RNA cpm. (d) 28S RNA cpm. (e) The sum 
of the 32S  RNA  +  28S cpm. (]) 32S RNA cpm. 
TABLE I11 
Cpm Ratios of Various rRNA Species When [Methyl-SH]DRB 45S RNA is Processed after the Inhibitor Has 
Been Removed 
Ratios of [Methyl-aH}cpm 
A(32S + 28S)  AI8S 
Sam pie  Time of chase  A 18S  % of theoretical  A45S  % of theoret ical 
Theoretical* 
50 ug/ml DRB 
%  % 
1.7  0.37 
30 min  0.72  42  0.21  57 
1 h  0.46  27  0.24  65 
2 h  0,26  15  0.34  92 
Control  30 min  1.66  98  0.43  116 
The cpm of the individual rRNA species were estimated from the gel curves in Fig. 9. The change in labeling of the 
various  rRNA  species from  time zero  of the chase was  calculated  for each time point. The ratios of these cpm 
differences were calculated and compared to the theoretical methyl group distributions. 
* Calculated from HeLa cell data of Weinberg and Penman (35). 
the 32S  rRNA  preribosomes were made but were 
very unstable. 
DRB Does Not Directly Modify 
Processing Enzyme Function to Cause 
This Degradation of Preribosomes 
This  conclusion  has  been  suggested  by  two 
pieces of experimental evidence: (a) Fig.  10 b  with 
its  semilog  inset  indicates  that  the  half-life  of 
[methyl-SH]45S  RNA  in  both  the  DRB-treated 
and control cells is nearly the same (approximately 
15  min).  It  appears  therefore  that,  for  the  45S 
RNA preribosomes made in the presence of DRB, 
processing is initiated at the same rate as in control 
cells after DRB has been removed. 
(b)  In  another  pulse-chase  experiment  (data 
reported  in my thesis [8]), normal prelabeled 45S 
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sequence  of  labeling  and  DRB  addition  in  this 
experiment was the reverse of that reported in Fig. 
9.  Normal  45S  RNA  preribosomes were  prela- 
beled by pulsing CEF cells with  label for a  time 
just  sufficient to  I'abel the  45S  RNA;  DRB  was 
then  added and  further labeling of newly synthe- 
sized RNA  was  stopped  by adding a  cold chase. 
After 1 h  of chase in the presence of DRB, when 
appreciable  amounts  of  normal  prelabeled  45S 
RNA had been processed to labeled 32S, 28S, and 
18S  RNAs,  it  was  found that  little 32S and 28S 
RNA (20% at most) had been lost. In other words, 
DRB  did  not  directly  cause  the  processing  en- 
zyme(s)  to  make  abnormal  products  from  the 
normal 45S RNA preribosomes. 
These two experiments suggest that the process- 
ing enzyme action itself is unaffected by DRB. One 
may  conclude  therefore  that  the  degradation  of 
preribosomes which  have been  synthesized in the 
presence of DRB must be caused by some defect in 
the preribosomes themselves. 
In both the [~H]uridine experiment (Fig. 7) and 
the  [rnethyl-3H]methionine  experiment (Fig. 9) it 
was observed that labeled 45S rRNA accumulated 
in the presence of DRB at only half the rate seen in 
the  control  cells.  This  close  correspondence  in 
rates between [~H]methyl labeling and [3H]uridine 
labeling suggests:  (a)  that  the  defective preribo- 
somes  synthesized  in  the  presence of DRB  were 
probably  normally  methylated,  and  (b)  that  the 
factor used for calculation of inhibition of [3H]uri- 
dine  uptake  into  the  cell by  DRB  (Table  I) was 
probably correct. 
DISCUSSION 
A  number  of  adenosine  analogues,  including  a 
high  concentration  of adenosine  itself,  act  in  a 
similar  fashion  to  cause  dispersal of nucleoli in 
chick embryo fibroblast cells into beaded strands 
or NN (9). Reversal back to the normal nucleolar 
state occurs after removal of the chemicals from 
the medium. The biochemical basis of this action 
was studied because it was considered that such an 
investigation  might  reveal details  of the  normal 
mechanism by which the nucleolus generates ribo- 
somes and maintains itself in a steady-state. It was 
also hoped that these compounds might prove to 
be  useful  inhibitors of specific biochemical steps 
for cell and viral growth. 
Of  the  five  NN-forming  chemicals studied  in 
this report, the action of the compound DRB was 
chosen for detailed investigation because this aden- 
osine analogue could not form hydrogen bonds in 
the RNA polymerase base-pairing mechanism and 
therefore  could  not  be  inserted  into  growing 
RNAs. 
Effects of DRB 
DRB  appears  to  interfere  primarily with  the 
production of mRNA and rRNA in CEF cells. In 
the  presence  of  50  pg/ml  DRB  the  following 
effects were produced: (a) Inhibition of total RNA 
synthesis occurred  within  10-15  min  after  DRB 
addition (Fig. 3), suggesting that there was a direct 
interference  with  RNA  synthesis;  (b)  HnRNA 
synthesis was almost completely inhibited (Fig. 4); 
(c) mRNA  synthesis (as determined by following 
the  production  of an  inducible enzyme  in  chick 
embryo  liver cells) appeared to  be  almost  com- 
pletely inhibited (Table II); (d) the rate of accumu- 
lation of 45S rRNA was inhibited by 50% (Figs. 7 
and 8); (e) the rate of appearance of the final 18S 
rRNA ribosome product was inhibited 50% (Fig. 8 
c); (]) extensive (80%) degradation of the 32S and 
28S rRNA species occurred (Fig. 7; Table IlI); (g) 
only small amounts  of 18S  RNA  were degraded 
(approximately 20%)  (Table IlI). 
The data in this paper also suggest that most of 
the  preribosome  degradation  caused  by  DRB 
occurs  at  or  before  the  32S  RNA  preribosome 
stage (e.g., 41S intermediate stage?) (Fig. 10]). It 
also  appears  that  degradation  of these  preribo- 
somes  is  due  to  the  formation  of defective 45S 
RNA preribosomes containing 45S RNA and not 
to  a  direct  DRB  interference  with  the  rRNA 
processing enzyme action (Fig. 10 b; reference 8). 
The  defect  in  the  45S  rRNA  preribosomes 
produced in the presence of DRB is interpreted to 
reside in the protein content of the particle rather 
than  in  the  composition of its 45S  rRNA.  It  is 
unlikely that DRB causes major defects in the 45S 
rRNA  molecules  because  our  experiments  have 
shown  that the 45S rRNA  appears to be normal 
with respect to size and methyl content.  It is also 
unlikely that DRB is directly incorporated into the 
45S rRNA, in contrast to toyocamycin which was 
shown  to  be incorporated by Tavitian et  al. (29, 
30),  because  the  DRB  cannot  base  pair  in  the 
manner  required for the normal operation of the 
rRNA polymerase. We therefore propose that the 
45S rRNA preribosomes which are synthesized in 
the presence of DRB lack a proper protein coat. 
Evidence  that  protein-deficient  preribosomes 
can  be  subject  to  degradation during  the  subse- 
quent  processing steps is supplied by studies with 
cycloheximide and with hypertonic medium. These 
inhibitors of protein synthesis cause the synthesis 
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panying this synthesis of defective preribosomes is 
an extensive degradation of 28S rRNA and a lesser 
loss of 18S rRNA. The production of protein-defi- 
cient  preribosomes  occurs  well  before  the  2  h 
required to deplete the bulk of the preribosomal 
protein pool (33), suggesting that a fraction of the 
preribosomal proteins is more limited in supply (6, 
20). 
Effects of Other NN-Forming Chemicals 
The compounds toyocamycin and 2 mM adeno- 
sine were found to affect mRNA synthesis, rRNA 
synthesis, protein synthesis, and the processing of 
preribosomes, in a fashion similar to that of DRB 
(Figs.  1 and 6; Table II; reference 8). They may 
therefore inhibit ribosome production in CEF cells 
via a mechanism similar to that of DRB. 
Actions of DRB 
There are two possible ways in which DRB and 
the other NN-forming chemicals could be acting 
to decrease the  supply of preribosomal proteins: 
they  could  decrease  mRNA  production  at  the 
transcriptional levels, causing those polysome pro- 
teins made from short-lived mRNAs to gradually 
disappear from the cytoplasm; or the NN-forming 
chemicals could decrease all preribosomal protein 
synthesis directly at the translational level by in- 
hibiting the rate of initiation of protein synthesis 
on the polysomes. 
Evidence  for  direct  inhibition  at  the  transla- 
tional  level  by  actinomycin  D,  MPB,  and  cor- 
dycepin,  i.e.,  inhibitors previously considered  to 
act  only at the transcriptional level, has recently 
been presented by Singer and Penman (25) and by 
Craig  (5)  for  the  HeLa  and  L  cell  systems. 
However,  other  data  suggest  that  the  mode  of 
action  of  these  RNA  synthesis  inhibitors  may 
vary  with  cell  type  and  the  particular  spec- 
trum of proteins examined. For example, when L 
cells were  treated  with  actinomycin  D  or  MPB, 
total  [SH]leucine  incorporation  was  appreciably 
inhibited after 2 h and decreased by 50% after 4-h 
exposure to the inhibitor (5). This relatively rapid 
drop in the rate of protein synthesis was consistent 
with a mechanism of inhibition at the translational 
level.  In  contrast,  in  more  specialized  types  of 
cells, protein synthesis was often markedly insensi- 
tive to actinomycin D, as in the case of the protein 
secreted  by  the  colleterial gland  tubules  of the 
Cecropia moth (13) and in the case of the produc- 
tion  of serum  albumin  in  cultured chick embryo 
liver cells (15). In rat liver, actinomycin D caused a 
rapid  decrease  in  the  synthesis  of catalase,  but 
almost  no  decrease  in  the  synthesis of ornithine 
transcarbamylase  (32).  In  a  longer  incubation 
period of 20 h, using the chick embryo liver culture 
system of this paper, actinomycin D (0.25 ug/ml) 
caused an inhibition of total RNA synthesis of 82 
•  6%, whereas the inhibition on protein synthesis 
was only 24  a:  16% (S, Sassa, personal communi- 
cation). Such data imply that there are classes of 
polysomes which  are  relatively insensitive to  ac- 
tinomycin  D  inhibition at  the  translational level 
and that  protein synthesis may continue uninhib- 
ited when the mRNAs have a long half-life. 
Our  data  suggest  that  in  the  CEF  cells  the 
inhibition of ribosomal protein synthesis by DRB 
and  the  other  NN-forming  chemicals  probably 
occurs  as the  indirect  result  of the  inhibition of 
mRNA  production  and  is  not  due  to  a  general 
inhibition of protein synthesis at the translational 
level.  After  DRB  addition  to  CEF  cells,  the 
inhibition  of  total  RNA  synthesis  was  rapid 
(within 15 min) and extensive, the accumulation of 
rRNA and HnRNA being decreased 50 and 95%, 
respectively. Protein synthesis, however, was only 
slightly affected by DRB. [~'C]Leucine incorpora- 
tion was approximately normal after 2-h exposure 
to 50 t~g/ml DRB or to 2 mM adenosine (Fig. 1). 
By this time large amounts of 28S and 32S RNAs 
had already been lost (Fig. 7).  After 4 h  of DRB 
treatment, protein synthesis had still only slightly 
decreased  (10-20%).  Our  postulate  that  DRB 
interference  with  preribosome production  results 
from  the  inhibition  of  mRNA  synthesis is  also 
supported by the  observation that  a-amanitin,  a 
known inhibitor of the mRNA polymerase, causes 
NN formation in CEF cells with an accompanying 
degradation of 32S RNA preribosomes in a man- 
ner very similar to that observed in the presence of 
DRB (reference 9; Fig. 7). 
Although our data indicate that actinomycin D 
and  DRB  do  not  inhibit  the  bulk  of CEF  cell 
protein synthesis directly at the translational level, 
we cannot at this time rule out the possibility that 
these chemicals may be slowing the translation of 
only  a  limited number  of proteins,  such  as  pre- 
ribosomal proteins.  Nor  have  we  eliminated the 
possibility that the rates of RNA synthesis may be 
normal in the presence of DRB but that DRB may 
be causing an increased rate of RNA degradation 
thus decreasing HnRNA and 45S RNA pools. It is 
hoped that the use of cell-free systems may permit 
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action of DRB. 
Model for DRB Interference with 
Ribosomal Production in CEF Cells 
We  propose  a  model  for  DRB  action  which, 
although not proven by the data in this paper, may 
be  useful  for  planning  future  studies.  My  model 
(Fig.  11) assumes that the primary sites of inhibi- 
tory action of DRB  and  related analogues are at 
the  rRNA  polymerase  and  mRNA  polymerase 
levels. As a consequence of the partial inhibition of 
the  rRNA  polymerase,  the  rate  of  45S  RNA 
synthesis  and  the  rate  of  appearance  of  18S 
products  are  slowed  by  50%.  Furthermore,  as a 
consequence of the almost complete inhibition of 
mRNA  synthesis,  a  certain  number  of the  pre- 
ribosomal  protein  species  may  become  limiting, 
resulting  in  the  production  of  protein-deficient 
preribosomes. DRB would stop the production of 
these special proteins by inhibiting the production 
of  their  mRNAs.  I  propose  that  these  missing 
proteins are (a) normally limited in supply and (b) 
have  relatively short  lived mRNAs,  so that  after 
the addition of DRB the supply of these proteins 
rapidly decreases, i.e. in less than 30 min. 
The  protein-deficient  45S  rRNA-containing 
preribosomes, synthesized in the presence of DRB, 
are stable because they have the same half-life as 
normal 45S  RNA  preribosomes (Fig.  10 b).  The 
18S  rRNA  preribosomes cleaved from  them  are 
also stable. However, the larger preribosome parti- 
cle is highly susceptible to degradation either at the 
32S  RNA  stage  or  at  some  time  during  the 
processing steps which  lead to the  production  of 
the  32S  RNA  preribosome  particle.  One  might 
envision that, after the cleavage of the 45S RNA 
preribosome  by  the  endoribonuclease  processing 
enzyme, protein-deficient regions of the precursor 
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FIGURE  l I  Model of DRB action.  DRB inhibits rRNA synthesis by 50%. It inhibits mRNA synthesis 
almost completely; only long-lived mRNA is translated on the polysornes. As a consequence, the protein 
coat of the 32S RNA preribosomes is deficient in the proteins translated from short-lived mRNAs. This 
protein-deficient 32S RNA preribosome is then susceptible to degradation. 
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nuclease attack, perhaps by the same endoribonu- 
clease  which  specifically cleaves normal  preribo- 
somes. 
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Note Added in Proof." Green and Chan (Green, H., and 
T.  S.  Chan.  1973. Pyrimidine  starvation  induced  by 
adenosine  in  fibroblasts  and  lymphoid  cells.  Science 
[Wash.  D.  C.]. 182:836),  have  suggested  that  in  their 
mammalian  fibroblast  and  lymphoid  cells  adenosine 
inhibited the  de  novo  synthesis of pyrimidines. How- 
ever, in our CEF cell system given 2 mM adenosine it is 
unlikely  that  a decrease in the intracellular pyrimidine 
level was the primary factor responsible  for NN forma- 
tion. This is inferred because high concentrations (2 mM) 
of cytidine and  uridine,  added  along  with  the  2  mM 
adenosine to the CEF cells did not overcome NN forma- 
tion (8). 
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